About 4 results found for searched term "BET BD2-IN-1" (0.119 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41655 | BET BD2-IN-1 | Epigenetic Reader Domain |
| BET BD2-IN-1 is a potent and selective inhibitor of BET BD2 (IC50=1.6 nM). | ||
| M10759 | GSK046 | Epigenetic Reader Domain |
| iBET-BD2 | ||
| GSK046 (iBET-BD2) is an effective, selective and orally active inhibitor of the BD2 bromine domain of the BET protein,IC50 The values are 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2), and 214 nM (BRDT BD2). GSK046 has immunomodulatory activity. | ||
| M29430 | BY27 | Epigenetic Reader Domain |
| BY27 is a potent and selective BET BD2 inhibitor, shows 38, 5, 7, and 21-fold BD1/BD2 selectivity for BRD2, BRD3, BRD4, and BRDT. Anti-cancer activity. | ||
| M29795 | GSK040 | Epigenetic Reader Domain |
| GSK040 is a potent and highly selective BET BD2 inhibitor, with a pIC50 of 8.3. GSK040 shows more than 5000-fold selectivity for BET BD2 over BET BD1 (pIC50=4.6). GSK040 can be used for the research of oncology and immunology diseases. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
